Skip to main content

A first in category prescription regimen for ADHD combining stimulants with intelligent dosing and digital capabilities

Project description

Innovative technological solution to provide intelligent dosing in ADHD

Call for proposal

H2020-SMEInst-2018-2020-1
See other projects for this call

Coordinator

ONDOSIS AB
Address
Astrazeneca Bioventurehub, Peppared
431 50 Molndal
Sweden
Activity type
Private for-profit entities (excluding Higher or Secondary Education Establishments)
EU contribution
€ 50 000